Evidence & Performance Blog

As we know there is currently no reliable data on workload measurements nor proven methods which results in unrealistic performance expectations, excessive workload and inefficiency. It is crucial to know the time required to complete a dedicated task, the necessary resources to participate to a clinical trial.

The European Organization for Research and Treatment of Cancer (EORTC) has developed a Workload Measurement Instrument (WMI), used to record the time spent on main activites and the to calculate the cost of recruiting subjects to oncology trials.

Read more

If you want to understand why the pharmaceutical industry is currently undergoing a transition, I am recommending you to read this interesting report from PricewaterhouseCoopers.

PWC clearly “indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.”

As I mentioned earlier, it is clear that the Pharma. must quickly find the way to improve its R&D productivity. For us, it is only by measuring the performance that the companies are able to set goals and drive for improvement. This has been demonstrated in others business as finance, and ultimately will prove itself in Drug or Medical Device Development.

Do not hesitate to share your impression with us! 

Pharma 2020 : The vision - which path will you take?
A report from PricewaterhouseCoopers

US-Based eClinical specialist, Datatrak is about to close its doors in Bonn, Germany, first pionner in the industry in Europe in the 90’s.
As Datatrak is now exclusively using their new EDC platform, the support service on their legacy platform has to be reduced – last trial is supposed to last till late 2009.

Read more

YES ! This is just amazing!

Time between last patient’s visit and announcement of the clinical trial results took a bit less than seven weeks! Yes seven weeks, where it usually takes months, to get the final results out!
This happened to a sponsor with the help of Nextrials support and its EDC Software Prism!

Read more

ClinPhone, the world’s leading Clinical Technology Organization, will be acquired within the next couple of months.

CRO Parexel already made a $182 million bid, however Quintiles is discussing the acquisition azs well, and if they agree it will most likely be more than what Parexel offers.

Read more

Since we started, with Evidence, to talk about performance metrics in the clinical environment, I’m trying to obtain a clear picture of the active actors in this domain of expertise.

After few months, it becomes clear to me that it is not so easy to obtain this picture perhaps because we are facing a really emerging market with very few initiatives so far. Nevertheless, I think that this type of information could be very valuable for everyone in the community who shares our interest in this matter.

Read more

As the sponsors are more and more focused on the clinical trial performance, they now also seem focused on their service providers. Let’s see why they are interested in their provider’s performance, how they can get to results and at the bottom line what impact it will have on their future trials. Read more

All new medical products (drugs and medical devices) must follow harsh process of clinical development.

Starting from the earliest stage to very last step in the process of the clinical trial, there is place for potential delays and unexpected costs. Read more